Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Does Not Use Testing Behind New York ‘Cease And Desist’ On Major Retailers’ Herbals

This article was originally published in The Tan Sheet

Executive Summary

A N.Y. investigation showed GNC, Target, Walgreens and Walmart products “either could not be verified to contain the labeled substance” or contained ingredients not listed on labels. FDA says it does not use the testing method employed in the investigation, and trade groups criticize it as inappropriate to analyze herbal ingredients.

You may also be interested in...



Dietary Ingredient Identity Testing Exemptions Remain A Puzzle

The trade groups ask FDA to keep open the door for supplement firms to petition for 100% identity testing exemptions under an IFR published in 2007. AHPA and NPA say supplement manufacturers have insufficient guidance on information the agency expects in petitions for identity testing waivers.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel